Oncology — MCQs
On this page
Which parameter best predicts the return of renal function in a patient with tumor lysis syndrome?
Which of the following statements regarding the Philadelphia chromosome is NOT true?
A 32-year-old man presents with a serum sodium of 125 mEq/L. On examination, his blood pressure is 110/70 mmHg and pulse is 110/min. When sitting up, he feels lightheaded with a drop in blood pressure. His urine sodium is 5 mEq/L and urine osmolality is 800 mOsm/kg. What is the most likely diagnosis for this patient's hyponatremia?
What is the treatment of choice for anti-CD120 antibody?
A 50-year-old woman presents with pain and swelling in her proximal interphalangeal joints, wrists, and knees, accompanied by morning stiffness. She has a history of hysterectomy 10 years ago. Physical examination reveals swelling and synovial thickening of the proximal interphalangeal (PIP) joints. Her laboratory findings include: Hemoglobin 10.3 g/dL, MCV 80 fL, serum iron 28 mg/dL, iron-binding capacity 200 mg/dL, and saturation 14%. What is the most likely explanation for this woman's anemia?
A 19-year-old man presents to the emergency department with symptoms of malaise, nausea, and decreased urine output. He was previously well, and his physical examination is normal except for an elevated jugular venous pressure (JVP) and a pericardial rub. His electrolytes reveal acute kidney injury (AKI). Which of the following findings on the urinalysis is most likely in keeping with acute glomerulonephritis (GN)?
Which of the following statements regarding oat cell carcinoma of the lung is FALSE?
A 69-year-old man with a 60 pack-year smoking history presents with dizziness and visual disturbances. Physical examination reveals a purplish discoloration of his face, arms, and neck; retinal vein engorgement; and visible distention of his neck veins. His complete blood count reveals a normocytic anemia. The pathophysiology of this patient’s clinical presentation most likely involves which of the following?
Which of the following is the most common functioning pancreatic islet cell tumor?
The mutation of the Wilms' tumor gene is located on which chromosome band?
Oncology Indian Medical PG Practice Questions and MCQs
Question 141: Which parameter best predicts the return of renal function in a patient with tumor lysis syndrome?
- A. Serum creatinine
- B. Serum phosphate
- C. Serum potassium
- D. Serum uric acid (Correct Answer)
Explanation: **Explanation:** **Tumor Lysis Syndrome (TLS)** is an oncologic emergency characterized by the massive release of intracellular contents into the bloodstream. The primary mechanism of acute kidney injury (AKI) in TLS is **Urate Nephropathy**, where uric acid crystals precipitate in the renal tubules, leading to obstruction and inflammation [1]. **Why Serum Uric Acid is the best predictor:** The recovery of renal function in TLS is directly linked to the clearance of the obstructing agent. As serum uric acid levels decrease (either through aggressive hydration, urinary alkalinization, or the use of Rasburicase), the intratubular crystal burden diminishes. A significant drop in serum uric acid levels precedes the improvement in glomerular filtration rate (GFR), making it the most reliable biochemical predictor of the return of renal function. **Why other options are incorrect:** * **Serum Creatinine:** This is a marker of *current* renal function (damage), not a predictor of recovery [2]. Creatinine levels often remain elevated for days after the underlying cause of AKI is resolved due to the time required for tubular repair. * **Serum Phosphate:** While hyperphosphatemia causes calcium-phosphate deposition (nephrocalcinosis), it is secondary to uric acid in terms of the initial obstructive insult in TLS [1]. * **Serum Potassium:** Hyperkalemia is the most life-threatening electrolyte derangement in TLS, but it reflects cell lysis and renal failure severity rather than predicting the reversal of the pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** Allopurinol (prevents new uric acid formation). * **Treatment of choice for Hyperuricemia:** **Rasburicase** (recombinant urate oxidase) – it converts uric acid into highly soluble allantoin. * **Cairo-Bishop Definition:** Laboratory TLS (2 or more metabolic abnormalities) vs. Clinical TLS (Lab TLS + increased creatinine, seizures, or arrhythmias). * **Classic Tetrad:** Hyperuricemia, Hyperkalemia, Hyperphosphatemia, and **Hypocalcemia** (due to phosphate binding).
Question 142: Which of the following statements regarding the Philadelphia chromosome is NOT true?
- A. Present in 95% of chronic myeloid leukemia (CML) patients.
- B. It is the result of a reciprocal translocation.
- C. Specific for CML. (Correct Answer)
- D. Designated as t(9;22)(q34;q11).
Explanation: The Philadelphia (Ph) chromosome is the hallmark of Chronic Myeloid Leukemia (CML), but it is not exclusive to it. **Explanation of the Correct Answer (C):** The statement "Specific for CML" is **incorrect** because the Philadelphia chromosome is also found in other hematological malignancies. It is present in approximately **25-30% of adults with Acute Lymphoblastic Leukemia (ALL)**, 2-5% of pediatric ALL, and occasionally in Acute Myeloid Leukemia (AML). In ALL, its presence signifies a poor prognosis [1]. **Analysis of Other Options:** * **Option A:** It is present in **>95% of CML patients**. The remaining 5% are "Ph-negative" but usually harbor the cryptic *BCR-ABL1* fusion gene detectable by FISH or PCR. * **Option B & D:** The Ph chromosome is a **reciprocal translocation** between chromosomes 9 and 22, designated as **t(9;22)(q34;q11)** [2]. This results in the fusion of the *ABL1* proto-oncogene (Ch 9) with the *BCR* gene (Ch 22), creating a chimeric protein with constitutive tyrosine kinase activity [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Molecular Weight:** The fusion protein in CML is typically **p210**, whereas in Ph+ ALL, it is often **p190**. 2. **Diagnosis:** While karyotyping identifies the Ph chromosome, **FISH** is more sensitive, and **RT-PCR** is the gold standard for monitoring Minimal Residual Disease (MRD) [3]. 3. **Treatment:** The first-line treatment for Ph+ CML is **Imatinib** (a Tyrosine Kinase Inhibitor) [2], [3]. 4. **Blast Crisis:** CML can transform into either AML (70%) or ALL (30%) during a blast crisis.
Question 143: A 32-year-old man presents with a serum sodium of 125 mEq/L. On examination, his blood pressure is 110/70 mmHg and pulse is 110/min. When sitting up, he feels lightheaded with a drop in blood pressure. His urine sodium is 5 mEq/L and urine osmolality is 800 mOsm/kg. What is the most likely diagnosis for this patient's hyponatremia?
- A. Congestive heart failure (CHF)
- B. Extrarenal sodium and fluid losses (Correct Answer)
- C. Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH)
- D. Polydipsia
Explanation: The key to solving hyponatremia questions lies in assessing the patient's **volume status** and **urinary sodium (UNa)**. **1. Why "Extrarenal sodium and fluid losses" is correct:** The patient presents with **hypovolemic hyponatremia**, evidenced by tachycardia (110/min) and **orthostatic hypotension** (lightheadedness and BP drop upon sitting). In response to volume depletion, the body activates the Renin-Angiotensin-Aldosterone System (RAAS) to conserve sodium [1]. * **Low Urine Sodium (<20 mEq/L):** Indicates that the kidneys are functioning correctly and attempting to retain sodium. This points to a loss occurring *outside* the kidneys (e.g., vomiting, diarrhea, or excessive sweating) [1]. * **High Urine Osmolality (>100 mOsm/kg):** ADH is appropriately secreted in response to hypovolemia to retain water, resulting in concentrated urine [2]. **2. Why the other options are incorrect:** * **Congestive Heart Failure (CHF):** While CHF causes hyponatremia with low UNa, it presents with **hypervolemia** (edema, JVP elevation, crackles), not orthostatic hypotension [1]. * **SIADH:** This is a **euvolemic** state [1]. Crucially, in SIADH, the UNa is typically **>40 mEq/L** because there is no stimulus for the RAAS to conserve sodium. * **Polydipsia:** Patients with primary polydipsia are euvolemic and have **dilute urine** (Urine Osmolality <100 mOsm/kg) or excessive electrolyte-free water intake [1]. **3. NEET-PG High-Yield Pearls:** * **Hypovolemic + UNa <20:** Extrarenal losses (GI, skin) [1]. * **Hypovolemic + UNa >40:** Renal losses (Diuretics, Addison’s disease, Salt-wasting nephropathy) [1]. * **Euvolemic + UNa >40:** SIADH, Hypothyroidism, Glucocorticoid deficiency [1]. * **Hypervolemic + UNa <20:** CHF, Cirrhosis, Nephrotic Syndrome [1]. * **Correction Warning:** Rapid correction of chronic hyponatremia (>8-10 mEq/L in 24h) can lead to **Osmotic Demyelination Syndrome (Central Pontine Myelinolysis)** [3].
Question 144: What is the treatment of choice for anti-CD120 antibody?
- A. All low-grade non-Hodgkin's lymphomas (Correct Answer)
- B. Relapsed B cell follicular lymphomas
- C. Relapsed Hodgkin's disease
- D. Chronic lymphatic leukemia
Explanation: The question refers to Rituximab, which is a chimeric monoclonal antibody directed against the CD20 antigen (note: "CD120" in the prompt is a common typographical error in some question banks for CD20; CD20 is the hallmark target for B-cell therapies) [1]. CD20 is expressed on the surface of normal and malignant B-lymphocytes. **Why Option A is Correct:** Rituximab is the standard of care and the treatment of choice for all low-grade non-Hodgkin's lymphomas (NHL), particularly B-cell types [1]. It works via antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity, and induction of apoptosis. It is used both as monotherapy and in combination with chemotherapy (e.g., R-CHOP, R-CVP) to significantly improve progression-free and overall survival in low-grade lymphomas like Follicular Lymphoma and Marginal Zone Lymphoma [1]. **Analysis of Incorrect Options:** * **Option B:** While Rituximab is used in relapsed follicular lymphoma, it is not restricted to relapsed cases; it is the primary choice for *initial* treatment as well [1]. * **Option C:** Hodgkin’s disease is characterized by Reed-Sternberg cells which are typically CD20 negative (they are CD15+ and CD30+). Therefore, anti-CD20 therapy is not the treatment of choice [2]. * **Option D:** In Chronic Lymphocytic Leukemia (CLL), while Rituximab is used (often in the FCR regimen), the expression of CD20 on CLL cells is typically weak. It is a component of treatment but "low-grade NHL" represents the broader, classic indication for this class. **High-Yield Clinical Pearls for NEET-PG:** * **Target:** CD20 (found on B-cells from pre-B stage to mature B-cells; absent on plasma cells). * **Side Effects:** Infusion-related reactions (most common), B-cell depletion, and **Reactivation of Hepatitis B** (mandatory screening required before starting therapy). * **Other Anti-CD20 Monoclonals:** Ofatumumab, Obinutuzumab. * **Radioimmunotherapy:** Ibritumomab tiuxetan (Yttrium-90 labeled anti-CD20).
Question 145: A 50-year-old woman presents with pain and swelling in her proximal interphalangeal joints, wrists, and knees, accompanied by morning stiffness. She has a history of hysterectomy 10 years ago. Physical examination reveals swelling and synovial thickening of the proximal interphalangeal (PIP) joints. Her laboratory findings include: Hemoglobin 10.3 g/dL, MCV 80 fL, serum iron 28 mg/dL, iron-binding capacity 200 mg/dL, and saturation 14%. What is the most likely explanation for this woman's anemia?
- A. Occult blood loss
- B. Vitamin deficiency
- C. Anemia of chronic disease (Correct Answer)
- D. Sideroblastic anemia
Explanation: The patient presents with clinical features classic for **Rheumatoid Arthritis (RA)**: symmetrical inflammatory polyarthritis involving the PIP joints and wrists with significant morning stiffness [1]. In the context of a chronic inflammatory state like RA, the most common cause of anemia is **Anemia of Chronic Disease (ACD)**. [2] **1. Why Anemia of Chronic Disease is correct:** In chronic inflammation, cytokines (especially IL-6) trigger the liver to produce **Hepcidin** [1]. Hepcidin inhibits **ferroportin**, preventing iron release from macrophages and decreasing intestinal iron absorption. This leads to "iron sequestration" [3]. * **Lab Profile in ACD:** Low serum iron, **low Total Iron Binding Capacity (TIBC)**, and normal-to-high ferritin. * In this case, the TIBC is low (200 mg/dL; normal 250–450), which is the hallmark that distinguishes ACD from Iron Deficiency Anemia (IDA). **2. Why the other options are incorrect:** * **A. Occult blood loss:** This leads to Iron Deficiency Anemia. While IDA also has low serum iron, it is characterized by a **high TIBC** (compensatory increase in transferrin), which is not present here. [3] * **B. Vitamin deficiency:** B12 or Folate deficiency causes megaloblastic anemia with a **high MCV** (>100 fL). This patient has a low-normal MCV (80 fL). * **C. Sideroblastic anemia:** This typically presents with **increased** serum iron and saturation due to the inability to incorporate iron into hemoglobin, often showing "ringed sideroblasts" in the bone marrow. **High-Yield Clinical Pearls for NEET-PG:** * **ACD vs. IDA:** The most reliable differentiator is **Ferritin** (Low in IDA, Normal/High in ACD) and **TIBC** (High in IDA, Low in ACD). * **Hepcidin** is the "master regulator" of iron metabolism and an acute-phase reactant [3]. * In RA, the severity of anemia usually correlates with the degree of joint inflammation and ESR/CRP levels.
Question 146: A 19-year-old man presents to the emergency department with symptoms of malaise, nausea, and decreased urine output. He was previously well, and his physical examination is normal except for an elevated jugular venous pressure (JVP) and a pericardial rub. His electrolytes reveal acute kidney injury (AKI). Which of the following findings on the urinalysis is most likely in keeping with acute glomerulonephritis (GN)?
- A. Proteinuria
- B. White blood cell casts
- C. Granular casts
- D. Erythrocyte casts (Correct Answer)
Explanation: ### Explanation **Correct Answer: D. Erythrocyte casts** The presence of **erythrocyte (red blood cell) casts** is the pathognomonic hallmark of **acute glomerulonephritis (GN)** [1]. In GN, the glomerular filtration barrier is damaged, allowing RBCs to leak into the nephron [2]. As these cells pass through the distal convoluted tubule and collecting duct, they are trapped within a matrix of Tamm-Horsfall mucoprotein, forming a cylindrical cast. Finding RBC casts definitively localizes the source of hematuria to the renal parenchyma (glomerulus) rather than the lower urinary tract [1]. **Analysis of Incorrect Options:** * **A. Proteinuria:** While common in GN, proteinuria is non-specific [2]. It can occur in nephrotic syndrome, tubular diseases, or even functional states like heavy exercise or fever. * **B. White blood cell (WBC) casts:** These are characteristic of **acute pyelonephritis** or **acute tubulointerstitial nephritis (AIN)** [3]. They indicate inflammation or infection within the kidney interstitium. * **C. Granular casts:** Often described as "muddy brown" casts, these are the hallmark of **Acute Tubular Necrosis (ATN)**. They represent degenerated tubular epithelial cells. **Clinical Pearls for NEET-PG:** * **Dysmorphic RBCs (Acanthocytes):** Along with RBC casts, these are highly suggestive of glomerular bleeding. * **Clinical Context:** In this 19-year-old patient, the combination of AKI, elevated JVP, and a pericardial rub suggests **uremic pericarditis**—a medical emergency requiring urgent dialysis [4]. * **Nephritic Syndrome Triad:** Hematuria (RBC casts), Hypertension, and Azotemia (AKI) [5]. * **High-Yield Association:** If a young male presents with hemoptysis and RBC casts, consider **Goodpasture Syndrome** (Anti-GBM disease) [3].
Question 147: Which of the following statements regarding oat cell carcinoma of the lung is FALSE?
- A. It is a variant of large cell anaplastic carcinoma. (Correct Answer)
- B. Chemotherapy is generally effective.
- C. Paraneoplastic syndromes may be present.
- D. It can cause the Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH).
Explanation: **Explanation:** **Oat cell carcinoma** is a historical synonym for **Small Cell Lung Cancer (SCLC)**. It is characterized by small, round-to-oval cells with scanty cytoplasm, hyperchromatic nuclei, and "salt-and-pepper" chromatin. 1. **Why Option A is the Correct Answer (The False Statement):** Oat cell carcinoma is a distinct neuroendocrine tumor and is **not** a variant of large cell anaplastic carcinoma. Large cell carcinoma is a subtype of Non-Small Cell Lung Cancer (NSCLC) characterized by large nuclei and prominent nucleoli. SCLC and Large Cell Carcinoma are histologically and clinically separate entities. 2. **Analysis of Other Options:** * **Option B:** SCLC is highly sensitive to chemotherapy and radiotherapy (though it has a high recurrence rate). It is considered a "systemic disease" at presentation, making chemotherapy the mainstay of treatment. * **Option C & D:** SCLC is the most common lung cancer associated with **paraneoplastic syndromes** due to its neuroendocrine origin [1]. It frequently secretes ectopic hormones, most notably **ADH (causing SIADH)** and **ACTH (causing Cushing Syndrome)** [1], [2]. It is also associated with Lambert-Eaton Myasthenic Syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Typically **central/hilar** (arises from neuroendocrine Kulchitsky cells). * **Strongest Association:** Almost exclusively seen in **smokers** [3]. * **Genetics:** Nearly 100% show mutations in **TP53 and RB1** genes. * **Azzopardi Effect:** A characteristic histological finding where DNA from necrotic tumor cells encrusts venule walls. * **Staging:** Uses "Limited" vs. "Extensive" stage rather than traditional TNM for treatment decisions [4].
Question 148: A 69-year-old man with a 60 pack-year smoking history presents with dizziness and visual disturbances. Physical examination reveals a purplish discoloration of his face, arms, and neck; retinal vein engorgement; and visible distention of his neck veins. His complete blood count reveals a normocytic anemia. The pathophysiology of this patient’s clinical presentation most likely involves which of the following?
- A. Right heart failure secondary to left heart failure
- B. Obstruction of the superior vena cava by a primary tumor arising in the lungs (Correct Answer)
- C. Metastatic disease to the cervical lymph nodes with compression of the jugular veins
- D. Polycythemia rubra vera
Explanation: ### Explanation **Correct Option: B (Obstruction of the superior vena cava by a primary tumor arising in the lungs)** The patient presents with the classic triad of **Superior Vena Cava (SVC) Syndrome**: facial/neck edema (purplish discoloration), venous distention, and neurological symptoms (dizziness, visual disturbances due to cerebral venous congestion). Given his 60 pack-year smoking history, the most likely etiology is **Bronchogenic Carcinoma** (Small Cell Lung Cancer is the most common malignant cause, though Non-Small Cell Lung Cancer is also frequent) [1]. The pathophysiology involves extrinsic compression or direct invasion of the thin-walled SVC by a mediastinal mass, leading to impaired venous drainage from the head, neck, and upper extremities into the right atrium. **Incorrect Options:** * **A: Right heart failure:** While it causes neck vein distention (JVP), it typically presents with dependent edema (legs), hepatomegaly, and ascites, rather than isolated upper-body plethora and retinal engorgement. * **C: Metastatic cervical lymphadenopathy:** While this can compress jugular veins, it rarely causes the global, bilateral upper-body congestion and SVC-territory venous collateralization seen here. * **D: Polycythemia rubra vera:** This can cause facial plethora (ruddy cyanosis) and hyperviscosity, but it would present with an **elevated** hemoglobin/hematocrit, whereas this patient has normocytic anemia. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of SVC Syndrome:** Malignancy (70-90%), specifically Lung Cancer and Lymphoma. * **Pemberton’s Sign:** Asking the patient to lift both arms above the head; facial flushing or inspiratory stridor indicates thoracic outlet obstruction/SVC syndrome. * **Imaging of Choice:** Contrast-enhanced CT of the chest (gold standard to visualize the obstruction and collateral circulation). * **Management:** Emergency radiotherapy or stenting if airway/cerebral edema is present; otherwise, treat the underlying malignancy (e.g., chemotherapy for Small Cell Lung Cancer) [1].
Question 149: Which of the following is the most common functioning pancreatic islet cell tumor?
- A. Gastrinoma
- B. Glucagonoma
- C. Insulinoma (Correct Answer)
- D. Vipoma
Explanation: **Explanation:** **Insulinoma** is the most common functioning pancreatic neuroendocrine tumor (pNET). These tumors arise from the beta cells of the pancreatic islets and are characterized by the autonomous secretion of insulin, leading to fasting hypoglycemia [1]. **Why Insulinoma is correct:** Statistically, insulinomas represent the most frequent functioning pNET [2]. Clinically, they present with the **Whipple Triad**: symptoms of hypoglycemia, low blood glucose levels (<50 mg/dL), and immediate relief of symptoms upon glucose administration [1]. Unlike many other pNETs, approximately 90% of insulinomas are benign, solitary, and small (<2 cm). **Why other options are incorrect:** * **Gastrinoma:** This is the second most common functioning pNET. It causes **Zollinger-Ellison Syndrome**, characterized by refractory peptic ulcers and diarrhea. While common, its incidence is lower than that of insulinoma. * **Glucagonoma:** A rare tumor of alpha cells [3]. It presents with the "4 Ds": Diabetes, Dermatitis (**Necrolytic Migratory Erythema**), Deep vein thrombosis, and Depression. * **Vipoma:** Also known as Verner-Morrison syndrome or **WDHA syndrome** (Watery Diarrhea, Hypokalemia, Achlorhydria). It is significantly rarer than insulinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 90s for Insulinoma:** 90% are benign, 90% are solitary, 90% are intrapancreatic, and 90% are <2 cm. * **Localization:** Most insulinomas are distributed equally across the head, body, and tail of the pancreas. * **MEN1 Association:** While most insulinomas are sporadic, they can be associated with Multiple Endocrine Neoplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Diagnosis:** The gold standard is the **72-hour supervised fast** showing elevated insulin and C-peptide levels during hypoglycemia [1].
Question 150: The mutation of the Wilms' tumor gene is located on which chromosome band?
- A. 13p
- B. 13q14
- C. 11p13 (Correct Answer)
- D. 11q13
Explanation: ### Explanation **Correct Answer: C. 11p13** **1. Why 11p13 is Correct:** Wilms' tumor (Nephroblastoma) is the most common primary renal tumor of childhood. The **WT1 gene**, a tumor suppressor gene essential for normal kidney and gonadal development, is located on **chromosome 11p13**. Mutations or deletions in this specific band lead to the development of Wilms' tumor, often as part of the **WAGR syndrome** (Wilms' tumor, Aniridia, Genitourinary anomalies, and intellectual disability/Range of developmental delays). **2. Analysis of Incorrect Options:** * **13p:** Chromosome 13p consists mostly of repetitive DNA sequences and ribosomal RNA genes; it is not associated with major tumor suppressor genes. * **13q14:** This is the locus for the **RB1 (Retinoblastoma) gene** [1]. Mutations here are associated with Retinoblastoma and Osteosarcoma, not Wilms' tumor. * **11q13:** This locus is associated with the **MEN1 gene** (Multiple Endocrine Neoplasia Type 1) and the *CCND1* (Cyclin D1) gene, often implicated in Mantle Cell Lymphoma and Breast Cancer. **3. Clinical Pearls for NEET-PG:** * **WT1 vs. WT2:** While WT1 is at **11p13**, the **WT2 gene** (associated with Beckwith-Wiedemann Syndrome) is located at **11p15.5**. * **Histology:** Look for the "Triphasic pattern" on microscopy—blastemal, stromal, and epithelial cells. * **Clinical Presentation:** Usually presents as a large, smooth, firm abdominal mass that **does not cross the midline** (unlike Neuroblastoma). * **Denys-Drash Syndrome:** Characterized by the triad of Wilms' tumor, early-onset nephrotic syndrome (diffuse mesangial sclerosis), and male pseudohermaphroditism; also linked to WT1 mutations.
Practice by Chapter
Cancer Biology and Carcinogenesis
Practice Questions
Principles of Cancer Diagnosis and Staging
Practice Questions
Solid Tumor Management
Practice Questions
Hematological Malignancies
Practice Questions
Cancer Emergencies
Practice Questions
Principles of Chemotherapy, Immunotherapy and Targeted Therapy
Practice Questions
Radiation Oncology Basics
Practice Questions
Palliative Care in Oncology
Practice Questions
Cancer Screening and Prevention
Practice Questions
Paraneoplastic Syndromes
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free